ACELRX PHARMACEUTICALS INC - FORM 10-K - EX-32.1 - CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - March 30, 2011

Attached files

file filename
10-K - ANNUAL REPORT ON FORM 10-K - ACELRX PHARMACEUTICALS INCd10k.htm
EX-31.2 - CERTIFICATION OF PFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - ACELRX PHARMACEUTICALS INCdex312.htm
EX-10.5 - FORMS OF STOCK OPTION GRANT NOTICE, STOCK OPTION EXERCISE NOTICE AND STOCK... - ACELRX PHARMACEUTICALS INCdex105.htm
EX-31.1 - CERTIFICATION OF PEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - ACELRX PHARMACEUTICALS INCdex311.htm
EX-10.3 - FORMS OF NOTICE OF GRANT OF STOCK OPTION, STOP OPTION AGREEMENT AND STOCK OPTION - ACELRX PHARMACEUTICALS INCdex103.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ACELRX PHARMACEUTICALS INCdex231.htm
EX-10.6 - FORM OF RESTRICTED STOCK UNIT GRANT NOTICE AND RESTRICTED STOCK UNIT AGREEMENT - ACELRX PHARMACEUTICALS INCdex106.htm

Exhibit 32.1

CERTIFICATION

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Richard A. King, Chief Executive Officer of AcelRx Pharmaceuticals, Inc. (the “Company”), and James H. Welch, Chief Financial Officer of the Company, each hereby certifies that, to the best of his or her knowledge:

 

1. The Company’s Annual Report on Form 10-K for the period ended December 31, 2010, to which this Certification is attached as Exhibit 32.1 (the “Annual Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act, and

 

2. The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

In Witness Whereof, the undersigned have set their hands hereto as of the 30th day of March, 2011.

 

/s/ Richard A. King        

     

/s/ James H. Welch        

Richard A. King      James H. Welch
Chief Executive Officer      Chief Financial Officer

“This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of AcelRx Pharmaceuticals, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.”

ACELRX PHARMACEUTICALS INC Reports